High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions

被引：0
|
作者：
Jorge Maurino
Javier Sotoca
Ángel P. Sempere
Luis Brieva
Carlos López de Silanes
Ana B. Caminero
María Terzaghi
Julia Gracia-Gil
Gustavo Saposnik
机构：
[1] Roche Farma,Medical Department
[2] Hospital Universitari Mútua de Terrassa,Department of Neurology
[3] Hospital General Universitario de Alicante,Department of Neurology
[4] Hospital Universitari Arnau de Vilanova,Department of Neurology
[5] Hospital Universitario de Torrejón,Department of Neurology
[6] Complejo Asistencial de Ávila,Department of Neurology
[7] University of Toronto,Decision Neuroscience Unit, Li Ka Shing Institute
[8] Complejo Hospitalario Universitario de Albacete,Department of Neurology
[9] University of Toronto,Division of Neurology, Department of Medicine, St. Michael’s Hospital
[10] University of Zurich,Laboratory for Social and Neural System Research, Department of Economics
来源：
The Patient - Patient-Centered Outcomes Research | 2021年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 248
页数：7
相关论文
共 50 条
  • [21] Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?
    Cohen, Jeffrey A.
    Cross, Anne H.
    JAMA NEUROLOGY, 2023, 80 (07) : 669 - 672
  • [22] Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
    Filippi, Massimo
    Amato, Maria Pia
    Centonze, Diego
    Gallo, Paolo
    Gasperini, Claudio
    Inglese, Matilde
    Patti, Francesco
    Pozzilli, Carlo
    Preziosa, Paolo
    Trojano, Maria
    JOURNAL OF NEUROLOGY, 2022, 269 (10) : 5382 - 5394
  • [23] The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review
    Shahtaheri, Rahil Sadat
    Nikfar, Shekoufeh
    Khorasani, Elahe
    Sabbagh-Baniazad, Mansoureh
    Goudarzi, Zahra
    Emamikhah, Maziar
    CURRENT JOURNAL OF NEUROLOGY, 2020, 19 (03): : 138 - 145
  • [24] Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies
    Bridge, Francesca
    Brotherton, Julia
    Stankovich, Jim
    Sanfilippo, Paul G.
    Skibina, Olga G.
    Buzzard, Katherine
    Kalincik, Tomas
    Nguyen, Ai-Lan
    Guo, Kylie
    Monif, Mastura
    Wrede, C. David
    Rath, Louise
    Taylor, Lisa
    Butzkueven, Helmut
    Jokubaitis, Vilija G.
    van der Walt, Anneke
    NEUROLOGY, 2024, 102 (04) : 1 - 13
  • [25] Disease-modifying therapy in relapsing-remitting multiple sclerosis: efficacy is paramount
    Cristiano, E
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 3 - 7
  • [26] Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis
    Rosa C. Lucchetta
    Fernanda S. Tonin
    Helena H. L. Borba
    Letícia P. Leonart
    Vinicius L. Ferreira
    Aline F. Bonetti
    Bruno S. Riveros
    Jefferson Becker
    Roberto Pontarolo
    Fernando Fernandez-Llimós
    Astrid Wiens
    CNS Drugs, 2018, 32 : 813 - 826
  • [27] Sequencing of disease-modifying therapies for relapsing-remitting multiple sclerosis: a theoretical approach to optimizing treatment
    Grand'Maison, Francois
    Yeung, Michael
    Morrow, Sarah A.
    Lee, Liesly
    Emond, Francois
    Ward, Brian J.
    Laneuville, Pierre
    Schecter, Robyn
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (08) : 1419 - 1430
  • [28] Discontinuation of disease-modifying therapies in relapsing remitting multiple sclerosis - outcome and prognostic factors
    Bsteh, G.
    Feige, J.
    Ehling, R.
    Hegen, H.
    Auer, M.
    Di Pauli, F.
    Deisenhammer, F.
    Berger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 644 - 644
  • [29] Effectiveness of high-efficacy disease-modifying therapies in naive patients with relapsing-remmiting multiple sclerosis compared with the escalation regimen
    Gifreu-Fraixino, Ariadna
    Boix-Lago, Almudena
    Alvarez-Bravo, Gary
    Quiroga-Varela, Ana
    Miguela-Benavides, Albert
    Huertas-Pons, Joana M.
    Coll-Martinez, Claudia
    Ramio-Torrenta, Lluis
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1089 - 1089
  • [30] Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis
    Filippi, Massimo
    Danesi, Romano
    Derfuss, Tobias
    Duddy, Martin
    Gallo, Paolo
    Gold, Ralf
    Havrdova, Eva Kubala
    Kornek, Barbara
    Sacca, Francesco
    Tintore, Mar
    Weber, Joerg
    Trojano, Maria
    JOURNAL OF NEUROLOGY, 2022, 269 (03) : 1670 - 1677
12345